VIRX (Viracta) Pangali Forward P/E

Simbol resmi perusahaan Viracta Therapeutics, Inc. (VIRX)

Viracta Therapeutics is implementing ethical ESG standards into the development of anti-cancer agents, and on GURU.Markets, the company's forward P/E ratio confirms a trend with the metric standing at 0.00. The business capitalization relies on the future commercialization of Epstein-Barr virus therapy, while production facilities and research centers operate in accordance with strict international sterility regulations.

viracta.com - Pangali Forward P/E VIRX (periode 04.07.2022 - 16.02.2025)

Ringkesan rincian data analitis Viracta Therapeutics, Inc. (VIRX)

Analisis umum perusahaan:viracta.com
Produk merek viracta.com

For Viracta Therapeutics (VIRX), the forward P/E measures the market value of the business through the lens of expected earnings, accounting for the potential to set high prices for orphan cancer therapy drugs. By analyzing the fluctuations in the company's forward P/E, an investor gains a real-time assessment of future cash flows, making it possible to timely identify whether the asset is overbought or to find an entry point before the biotech giant realizes its pricing power.

Pesaing utama

Pangali Forward P/E ONC|HALO (Halozyme Inc.) - Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E RVMD (revmed.com)|AAPG - Prakiraan rega marang bathi|CGON: Prakiraan rega marang bathi|URGN - Pangali Forward P/E|Bicara Bio (BCAX) - Rega marang bathi mangsa ngarep|Personalis Corp - Pangali mangsa ngarep rega marang bathi|ERAS (Erasca Inc) - Pangali Forward P/E|Rasio prakiraan rega marang bathi Delcath Systems, Inc. DCTH|Prakiraan rega marang bathi YMAB (Y-mAbs Corp)|Pangali Forward P/E Aura Bio (AURA)|Pangali Forward P/E CADL (Candel Therapeutics Inc.)|ARAY - Prakiraan rega marang bathi|SLS - Rega marang bathi mangsa ngarep|Actuate Therapeutics - Rasio kapitalisasi marang bathi mangsa ngarep|CTOR: Pangali Forward P/E|TuHURA (HURA) - Pangali Forward P/E|TARA (Protara Therapeutics Inc) - Pangali Forward P/E|FATE: Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E WHWK|TCRX (TScan) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Champions Oncology, Inc. CSBR|XBIT - Prakiraan rega marang bathi|CEL-SCI - Pangali Forward P/E|OSTX - Pangali Forward P/E|Radiopharm Theranostics Limited (RADX) - Rega marang bathi mangsa ngarep|ARTV - Kapitalisasi marang proyeksi bathi|Prakiraan rega marang bathi ANL|Rega marang bathi mangsa ngarep VERU|Pangali Forward P/E TPST|XLO: Rasio rega marang bathi sing dikarepake|Pangali Forward P/E RENB (Renovaro Inc.)|Mural Bio (MURA) - Rasio prakiraan rega marang bathi|Kairos Pharma Ltd - Pangali Forward P/E|Rasio rega marang bathi sing dikarepake OKUR|CytoMed Therapeutics Limited (GDTC) - Rega marang bathi mangsa ngarep|CRIS - Kapitalisasi marang proyeksi bathi|Prakiraan rega marang bathi APLM|Tharimmune (THAR) - Kapitalisasi marang proyeksi bathi|Prakiraan rega marang bathi ADVB (Advanced Biomed Inc.)|Genprex - Rasio rega marang bathi mangsa ngarep|Pangali Forward P/E CLDI (Calidi Biotherapeutics, Inc.)|SBFM - Prakiraan rega marang bathi|Xenetic Bio - Pangali Forward P/E|SLRX - Pangali Forward P/E|PPBT: Pangali Forward P/E|Rasio rega marang bathi mangsa ngarep AONC|BGNE (BeiGene Ltd) - Pangali Forward P/E|CKPT (Checkpoint Therapeutics, Inc) - Rasio kapitalisasi marang bathi mangsa ngarep|Pangali Forward P/E ELEV|Prakiraan rega marang bathi iCAD Corp ICAD|Rega marang bathi mangsa ngarep ikenaoncology.com IKNA|NTBL - Prakiraan rega marang bathi|MOR: Prakiraan rega marang bathi|NAYA (NAYA Bio) - Rasio rega marang bathi mangsa ngarep|AAPGV: Pangali Forward P/E